The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition
Curation statements for this article:-
Curated by eLife
eLife assessment
This potentially important paper reports on interactions between L1TD1, an RNA binding protein (RBP), and the ancestral LINE-1 retrotransposon from which it originates. Overall, the results support a model in which L1TD1 and LINE-1 ORF1p have synergistic effects on LINE-1 retrotransposition, but the evidence for whether this is through direct protein-protein interaction or through simultaneous interaction with LINE-1 RNA is currently incomplete.
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (eLife)
- Genetics and Genomics (eLife)
Abstract
Repression of retrotransposition is crucial for the successful fitness of a mammalian organism. The domesticated transposon protein L1TD1, derived from LINE-1 ORF1p, is an RNA-binding protein that is expressed only in some cancers and early embryogenesis. In human embryonic stem cells it is found to be essential for maintaining pluripotency. In cancer, L1TD1 expression is highly correlative with malignancy progression and as such considered a potential prognostic factor for tumors. However, its molecular role in cancer remains largely unknown. Our findings reveal that DNA hypomethylation induces the expression of L1TD1 in HAP1 human tumor cells. L1TD1 depletion significantly modulates both the proteome and transcriptome and thereby reduces cell viability. Notably, L1TD1 associates with LINE-1 transcripts and interacts with LINE-1 ORF1p protein, thereby facilitating LINE-1 retrotransposition. Our data suggest that L1TD1 collaborates with its ancestral LINE-1 ORF1p as an RNA chaperone, ensuring the efficient retrotransposition of LINE-1 retrotransposons, rather than directly impacting the abundance of L1TD1 targets. In this way, L1TD1 might have an important role not only during early development but also in tumorigenesis.
Article activity feed
-
-
-
Author response:
Public Reviews:
Reviewer #1 (Public Review):
Summary:
In their manuscript entitled 'The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition', Kavaklıoğlu and colleagues delve into the role of L1TD1, an RNA binding protein (RBP) derived from a LINE1 transposon. L1TD1 proves crucial for maintaining pluripotency in embryonic stem cells and is linked to cancer progression in germ cell tumors, yet its precise molecular function remains elusive. Here, the authors uncover an intriguing interaction between L1TD1 and its ancestral LINE-1 retrotransposon.
The authors delete the DNA methyltransferase DNMT1 in a haploid human cell line (HAP1), inducing widespread DNA hypo-methylation. This hypomethylation prompts abnormal expression of L1TD1. To scrutinize …
Author response:
Public Reviews:
Reviewer #1 (Public Review):
Summary:
In their manuscript entitled 'The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition', Kavaklıoğlu and colleagues delve into the role of L1TD1, an RNA binding protein (RBP) derived from a LINE1 transposon. L1TD1 proves crucial for maintaining pluripotency in embryonic stem cells and is linked to cancer progression in germ cell tumors, yet its precise molecular function remains elusive. Here, the authors uncover an intriguing interaction between L1TD1 and its ancestral LINE-1 retrotransposon.
The authors delete the DNA methyltransferase DNMT1 in a haploid human cell line (HAP1), inducing widespread DNA hypo-methylation. This hypomethylation prompts abnormal expression of L1TD1. To scrutinize L1TD1's function in a DNMT1 knock-out setting, the authors create DNMT1/L1TD1 double knock-out cell lines (DKO). Curiously, while the loss of global DNA methylation doesn't impede proliferation, additional depletion of L1TD1 leads to DNA damage and apoptosis.
To unravel the molecular mechanism underpinning L1TD1's protective role in the absence of DNA methylation, the authors dissect L1TD1 complexes in terms of protein and RNA composition. They unveil an association with the LINE-1 transposon protein L1-ORF1 and LINE-1 transcripts, among others.
Surprisingly, the authors note fewer LINE-1 retro-transposition events in DKO cells than in DNMT1 KO alone.
Strengths:
The authors present compelling data suggesting the interplay of a transposon-derived human RNA binding protein with its ancestral transposable element. Their findings spur interesting questions for cancer types, where LINE1 and L1TD1 are aberrantly expressed.
Weaknesses:
Suggestions for refinement:
The initial experiment, inducing global hypo-methylation by eliminating DNMT1 in HAP1 cells, is intriguing and warrants a more detailed description. How many genes experience misregulation or aberrant expression? What phenotypic changes occur in these cells?
The transcriptome analysis of DNMT1 KO cells showed hundreds of deregulated genes upon DNMT1 ablation. As expected, the majority were up-regulated and gene ontology analysis revealed that among the strongest up-regulated genes were gene clusters with functions in “regulation of transcription from RNA polymerase II promoter” and “cell differentiation” and genes encoding proteins with KRAB domains. In addition, the de novo methyltransferases DNMT3A and DNMT3B were up-regulated in DNMT1 KO cells suggesting the set-up of compensatory mechanisms in these cells. We will include this data set in the revised version of the manuscript.
Why did the authors focus on L1TD1? Providing some of this data would be helpful to understand the rationale behind the thorough analysis of L1TD1.
We have previously discovered that conditional deletion of the maintenance DNA methyltransferase DNMT1 in the murine epidermis results not only in the up-regulation of mobile elements, such as IAPs but also the induced expression of L1TD1 ((Beck et al, 2021), Suppl. Table 1 and Author response image 1). Similary, L1TD1 expression was induced by treatment of primary human keratinocytes or squamous cell carcinoma cells with the DNMT inhibitor aza-deoxycytidine (Author response image 2 and 3). These finding are in accordance with the observation that inhibition of DNA methyltransferase activity by azadeoxycytidine in human non-small cell lung cancer cells (NSCLCs) results in upregulation of L1TD1 (Altenberger et al, 2017). Our interest in L1TD1 was further fueled by reports on a potential function of L1TD1 as prognostic tumor marker. We will include this information in the revised manuscript.
Author response image 1.
RT-qPCR of L1TD1 expression in cultured murine control and Dnmt1 Δ/Δker keratinocytes. mRNA levels of L1td1 were analyzed in keratinocytes isolated at P5 from conditional Dnmt1 knockout mice (Beck et al., 2021). Hprt expression was used for normalization of mRNA levels and wildtype control was set to 1. Data represent means ±s.d. with n=4. **P < 0.01 (paired t-test).
Author response image 2.RT-qPCR analysis of L1TD1 expression in primary human keratinocytes. Cells were treated with 5-aza-2-deoxycidine for 24 hours or 48 hours, with PBS for 48 hours or were left untreated. 18S rRNA expression was used for normalization of mRNA levels and PBS control was set to 1. Data represent means ±s.d. with n=3. **P < 0.01 (paired t-test).
Author response image 3.
Induced L1TD1 expression upon DNMT inhibition in squamous cell carcinoma cell lines SCC9 and SCCO12. Cells were treated with 5-aza-2-deoxycidine for 24 hours, 48 hours or 6 days. (A) Western blot analysis of L1TD1 protein levels using beta-actin as loading control. (B) Indirect immunofluorescence microscopy analysis of L1TD1 expression in SCC9 cells. Nuclear DNA was stained with DAPI. Scale bar: 10 µm. (C) RT-qPCR analysis of L1TD1 expression in primary human keratinocytes. Cells were treated with 5-aza-2deoxycidine for 24 hours or 48 hours, with PBS for 48 hours or were left untreated. 18S rRNA expression was used for normalization of mRNA levels and PBS control was set to 1. Data represent means ±s.d. with n=3. *P < 0.05, **P < 0.01 (paired t-test).
The finding that L1TD1/DNMT1 DKO cells exhibit increased apoptosis and DNA damage but decreased L1 retro-transposition is unexpected. Considering the DNA damage associated with retro-transposition and the DNA damage and apoptosis observed in L1TD1/DNMT1 DKO cells, one would anticipate the opposite outcome. Could it be that the observation of fewer transposition-positive colonies stems from the demise of the most transposition-positive colonies? Further exploration of this phenomenon would be intriguing.
This is an important point and we were aware of this potential problem. Therefore, we calibrated the retrotransposition assay by transfection with a blasticidin resistance gene vector to take into account potential differences in cell viability and blasticidin sensitivity. Thus, the observed reduction in L1 retrotransposition efficiency is not an indirect effect of reduced cell viability.
Based on previous studies with hESCs, it is likely that, in addition to its role in retrotransposition, L1TD1 has additional functions in the regulation of cell proliferation and differentiation. L1TD1 might therefore attenuate the effect of DNMT1 loss in KO cells generating an intermediate phenotype (as pointed out by Reviewer 2) and simultaneous loss of both L1TD1 and DNMT1 results in more pronounced effects on cell viability.
Reviewer #2 (Public Review):
In this study, Kavaklıoğlu et al. investigated and presented evidence for the role of domesticated transposon protein L1TD1 in enabling its ancestral relative, L1 ORF1p, to retrotranspose in HAP1 human tumor cells. The authors provided insight into the molecular function of L1TD1 and shed some clarifying light on previous studies that showed somewhat contradictory outcomes surrounding L1TD1 expression. Here, L1TD1 expression was correlated with L1 activation in a hypomethylation-dependent manner, due to DNMT1 deletion in the HAP1 cell line. The authors then identified L1TD1-associated RNAs using RIP-Seq, which displays a disconnect between transcript and protein abundance (via Tandem Mass Tag multiplex mass spectrometry analysis). The one exception was for L1TD1 itself, which is consistent with a model in which the RNA transcripts associated with L1TD1 are not directly regulated at the translation level. Instead, the authors found the L1TD1 protein associated with L1-RNPs, and this interaction is associated with increased L1 retrotransposition, at least in the contexts of HAP1 cells. Overall, these results support a model in which L1TD1 is restrained by DNA methylation, but in the absence of this repressive mark, L1TD1 is expressed and collaborates with L1 ORF1p (either directly or through interaction with L1 RNA, which remains unclear based on current results), leads to enhances L1 retrotransposition. These results establish the feasibility of this relationship existing in vivo in either development, disease, or both.
-
eLife assessment
This potentially important paper reports on interactions between L1TD1, an RNA binding protein (RBP), and the ancestral LINE-1 retrotransposon from which it originates. Overall, the results support a model in which L1TD1 and LINE-1 ORF1p have synergistic effects on LINE-1 retrotransposition, but the evidence for whether this is through direct protein-protein interaction or through simultaneous interaction with LINE-1 RNA is currently incomplete.
-
Reviewer #1 (Public Review):
Summary:
In their manuscript entitled 'The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition', Kavaklıoğlu and colleagues delve into the role of L1TD1, an RNA binding protein (RBP) derived from a LINE1 transposon. L1TD1 proves crucial for maintaining pluripotency in embryonic stem cells and is linked to cancer progression in germ cell tumors, yet its precise molecular function remains elusive. Here, the authors uncover an intriguing interaction between L1TD1 and its ancestral LINE-1 retrotransposon.
The authors delete the DNA methyltransferase DNMT1 in a haploid human cell line (HAP1), inducing widespread DNA hypo-methylation. This hypomethylation prompts abnormal expression of L1TD1. To scrutinize L1TD1's function in a DNMT1 knock-out setting, …
Reviewer #1 (Public Review):
Summary:
In their manuscript entitled 'The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition', Kavaklıoğlu and colleagues delve into the role of L1TD1, an RNA binding protein (RBP) derived from a LINE1 transposon. L1TD1 proves crucial for maintaining pluripotency in embryonic stem cells and is linked to cancer progression in germ cell tumors, yet its precise molecular function remains elusive. Here, the authors uncover an intriguing interaction between L1TD1 and its ancestral LINE-1 retrotransposon.
The authors delete the DNA methyltransferase DNMT1 in a haploid human cell line (HAP1), inducing widespread DNA hypo-methylation. This hypomethylation prompts abnormal expression of L1TD1. To scrutinize L1TD1's function in a DNMT1 knock-out setting, the authors create DNMT1/L1TD1 double knock-out cell lines (DKO). Curiously, while the loss of global DNA methylation doesn't impede proliferation, additional depletion of L1TD1 leads to DNA damage and apoptosis.
To unravel the molecular mechanism underpinning L1TD1's protective role in the absence of DNA methylation, the authors dissect L1TD1 complexes in terms of protein and RNA composition. They unveil an association with the LINE-1 transposon protein L1-ORF1 and LINE-1 transcripts, among others.
Surprisingly, the authors note fewer LINE-1 retro-transposition events in DKO cells than in DNMT1 KO alone.
Strengths:
The authors present compelling data suggesting the interplay of a transposon-derived human RNA binding protein with its ancestral transposable element. Their findings spur interesting questions for cancer types, where LINE1 and L1TD1 are aberrantly expressed.
Weaknesses:
Suggestions for refinement:
The initial experiment, inducing global hypo-methylation by eliminating DNMT1 in HAP1 cells, is intriguing and warrants a more detailed description. How many genes experience misregulation or aberrant expression? What phenotypic changes occur in these cells? Why did the authors focus on L1TD1? Providing some of this data would be helpful to understand the rationale behind the thorough analysis of L1TD1.
The finding that L1TD1/DNMT1 DKO cells exhibit increased apoptosis and DNA damage but decreased L1 retro-transposition is unexpected. Considering the DNA damage associated with retro-transposition and the DNA damage and apoptosis observed in L1TD1/DNMT1 DKO cells, one would anticipate the opposite outcome. Could it be that the observation of fewer transposition-positive colonies stems from the demise of the most transposition-positive colonies? Further exploration of this phenomenon would be intriguing.
-
Reviewer #2 (Public Review):
In this study, Kavaklıoğlu et al. investigated and presented evidence for the role of domesticated transposon protein L1TD1 in enabling its ancestral relative, L1 ORF1p, to retrotranspose in HAP1 human tumor cells. The authors provided insight into the molecular function of L1TD1 and shed some clarifying light on previous studies that showed somewhat contradictory outcomes surrounding L1TD1 expression. Here, L1TD1 expression was correlated with L1 activation in a hypomethylation-dependent manner, due to DNMT1 deletion in the HAP1 cell line. The authors then identified L1TD1-associated RNAs using RIP-Seq, which displays a disconnect between transcript and protein abundance (via Tandem Mass Tag multiplex mass spectrometry analysis). The one exception was for L1TD1 itself, which is consistent with a model in …
Reviewer #2 (Public Review):
In this study, Kavaklıoğlu et al. investigated and presented evidence for the role of domesticated transposon protein L1TD1 in enabling its ancestral relative, L1 ORF1p, to retrotranspose in HAP1 human tumor cells. The authors provided insight into the molecular function of L1TD1 and shed some clarifying light on previous studies that showed somewhat contradictory outcomes surrounding L1TD1 expression. Here, L1TD1 expression was correlated with L1 activation in a hypomethylation-dependent manner, due to DNMT1 deletion in the HAP1 cell line. The authors then identified L1TD1-associated RNAs using RIP-Seq, which displays a disconnect between transcript and protein abundance (via Tandem Mass Tag multiplex mass spectrometry analysis). The one exception was for L1TD1 itself, which is consistent with a model in which the RNA transcripts associated with L1TD1 are not directly regulated at the translation level. Instead, the authors found the L1TD1 protein associated with L1-RNPs, and this interaction is associated with increased L1 retrotransposition, at least in the contexts of HAP1 cells. Overall, these results support a model in which L1TD1 is restrained by DNA methylation, but in the absence of this repressive mark, L1TD1 is expressed and collaborates with L1 ORF1p (either directly or through interaction with L1 RNA, which remains unclear based on current results), leads to enhances L1 retrotransposition. These results establish the feasibility of this relationship existing in vivo in either development, disease, or both.
-
-